Position in AMGN
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$1,611,071
-$61,623 QoQ
Shares Held
4,449
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,398
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EASTERN BANK holds $295,354,591 across 16 Drug Manufacturers - General names. AMGN ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,336 | $139,536,899 | |
| 2 | ABBV |
AbbVie Inc.
|
318,655 | $80,186,344 | |
| 3 | JNJ |
Johnson & Johnson
|
145,368 | $36,919,110 | |
| 4 | MRK |
Merck & Co., Inc.
|
191,760 | $24,641,159 | |
| 5 | NVO |
Novo Nordisk A S
|
122,583 | $5,876,628 | |
| 6 | PFE |
Pfizer Inc
|
88,290 | $2,126,023 | |
| 7 | AMGN |
Amgen Inc
This page
|
4,449 | $1,611,071 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
27,740 | $1,598,378 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,611,071 | 4,449 | Shares | Defined | 2026-07-01 | |
| 2026-03-31 | $1,672,694 | 4,754 | Shares | Defined | 2026-04-07 | |
| 2025-12-31 | $1,663,716 | 5,083 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $1,429,060 | 5,064 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $1,819,331 | 6,516 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $2,182,406 | 7,005 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,899,282 | 7,287 | Shares | Defined | 2025-01-13 | |
| 2024-09-30 | $2,369,531 | 7,354 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $595,842 | 1,907 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $574,894 | 2,022 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $621,835 | 2,159 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $543,432 | 2,022 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $448,924 | 2,022 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $573,430 | 2,372 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $628,234 | 2,392 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $535,549 | 2,376 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $578,080 | 2,376 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $573,596 | 2,372 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $593,920 | 2,640 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $490,158 | 2,305 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $561,843 | 2,305 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $573,506 | 2,305 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $529,965 | 2,305 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $712,918 | 2,805 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $662,059 | 2,807 | Shares | Sole | 2020-09-01 | |
| 2020-03-31 | $612,041 | 3,019 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||